Recent Press Releases

ACRO Holds Initial Meeting of CRO Forum, Begins Two-Way Dialogue With TransCelerate

WASHINGTON--The Association of Clinical Research Organizations, whose members account for approximately two-thirds of contract clinical development services, held the inaugural meeting of the...

Altasciences and ITR Laboratories Form a Strategic Alliance

LAVAL, Québec--Altasciences, a provider of early phase clinical research services, and ITR Laboratories, a nonclinical services organization, announced today their strategic alliance offering...

Almac Discovery Initiates Phase 1 Study of ALM201 for the Treatment of Patients with Advanced Ovarian Cancer and other Solid Tumours

ALM201 represents the first clinical stage programme for Almac Discovery Craigavon, N.I., UK, – Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative...

ICON Launches Medical Device & Diagnostics Research Group

DUBLIN--ICON plc, (ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of a new Medical...

Patheon Expands Comprehensive Active Pharmaceutical Ingredient Services with Acquisition of IRIX Pharmaceuticals

Number One Provider of Pharmaceutical Development Services Establishes Strong API Presence in U.S. Patheon , a leading global provider of high-quality drug development and delivery solutions to the...

Huntingdon Life Sciences and Harlan Laboratories to operate under new brand and name

Huntingdon (UK): Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in...

Enteris BioPharma Launches Contract Manufacturing within 32,000 Square Foot, FDA inspected and cGMP Compliant Facility

Cost-effective, high-quality production of API using microbial expression systems Boonton, NJ – Enteris BioPharma, Inc., an industry leader in oral peptide delivery, announced today the launch...

Charles River Laboratories Announces Planned Management Changes

Thomas F. Ackerman, Corporate Executive Vice President & Chief Financial Officer, Announces Planned Retirement in 2016 David R. Smith Will Transition to Chief Financial Officer Role Dr. Emily...

INC Research Reports Fourth Quarter and Full-Year 2014 Results

INC Research Reports Fourth Quarter and Full-Year 2014 Results Fourth Quarter 2014 Results (Compared to Fourth Quarter 2013) Net new business awards of $316.3 million, representing growth of 10.9%...

WuXi PharmaTech Enters into Syndicated Loan Agreement

SHANGHAI, Feb. 17, 2015 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical...

PAREXEL Simplifies Patient Recruitment And Study Start-Up Timelines Through Innovative Site Alliance Network

BOSTON -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the continued expansion of its clinical trial site alliance network,...

Theorem Clinical Research and Biomedical Systems Form Strategic Partnership to Expand Contract Services

KING OF PRUSSIA, Pa. & ST. LOUIS--Theorem Clinical Research, a prominent global contract research organization, andBiomedical Systems, a leading provider of comprehensive centralized diagnostic...

PRA Health Sciences, Inc. Reports 4th Quarter and Full Year 2014 Results and 2015 Guidance

$323.8 million of service revenue in the fourth quarter; 8% consolidated service revenue growth compared to the fourth quarter of 2013 $50.6 million of Adjusted EBITDA in the fourth quarter; 44%...

LabCorp Completes Acquisition of Covance

BURLINGTON, N.C.--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the completion of its acquisition of Covance Inc., following its entry into a definitive...

CROWN BIOSCIENCE ACQUIRES MOLECULAR RESPONSE'S PATIENT DERIVED XENOGRAFT (PDX) BUSINESS

SANTA CLARA, CA (12TH FEBRUARY 2015) – CROWN BIOSCIENCE, INC., A LEADING GLOBAL DRUG DISCOVERY AND DEVELOPMENT SERVICE COMPANY HAS ANNOUNCED THE ACQUISITION OF MOLECULAR RESPONSE'S PDX...

Evotec Adopts ChemAxon's Compliance Checker to Aid Controlled Substance Management

ChemAxon and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the licensing and deployment of ChemAxon's Compliance Checker technology and content package to...

SIRO Clinpharm Announces Relocation of Corporate Offices

SIRO Clinpharm, an award-winning Clinical Research Organization (CRO), announced relocation of its corporate headquarters withinMumbai, India, with effect from February 11, 2015. This move allows...

Catalent Reports Second Quarter Fiscal Year 2015 Results

SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health...

Actavis to Divest Pharmatech to TPG

DUBLIN and FORT WORTH, Texas -- Actavis plc (NYSE: ACT) and TPG, the global private investment firm, today announced that they have entered into definitive agreements, under which Actavis will divest...

AMRI Announces Fourth Quarter and Full Year 2014 Results

ALBANY, N.Y., Feb. 12, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2014. "While our OsoBio...